217 related articles for article (PubMed ID: 32479050)
1. How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.
Fang L; Vilas-Boas J; Chakraborty S; Potter ZE; Register AC; Seeliger MA; Maly DJ
ACS Chem Biol; 2020 Jul; 15(7):2005-2016. PubMed ID: 32479050
[TBL] [Abstract][Full Text] [Related]
2. Allosteric Modulation of Src Family Kinases with ATP-Competitive Inhibitors.
Register AC; Chakraborty S; Maly DJ
Methods Mol Biol; 2017; 1636():79-89. PubMed ID: 28730474
[TBL] [Abstract][Full Text] [Related]
3. Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors.
Leonard SE; Register AC; Krishnamurty R; Brighty GJ; Maly DJ
ACS Chem Biol; 2014 Aug; 9(8):1894-905. PubMed ID: 24946274
[TBL] [Abstract][Full Text] [Related]
4. SH2-catalytic domain linker heterogeneity influences allosteric coupling across the SFK family.
Register AC; Leonard SE; Maly DJ
Biochemistry; 2014 Nov; 53(44):6910-23. PubMed ID: 25302671
[TBL] [Abstract][Full Text] [Related]
5. Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.
Chakraborty S; Inukai T; Fang L; Golkowski M; Maly DJ
ACS Chem Biol; 2019 Jun; 14(6):1249-1259. PubMed ID: 31038916
[TBL] [Abstract][Full Text] [Related]
6. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
7. A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent Functions.
Ahler E; Register AC; Chakraborty S; Fang L; Dieter EM; Sitko KA; Vidadala RSR; Trevillian BM; Golkowski M; Gelman H; Stephany JJ; Rubin AF; Merritt EA; Fowler DM; Maly DJ
Mol Cell; 2019 Apr; 74(2):393-408.e20. PubMed ID: 30956043
[TBL] [Abstract][Full Text] [Related]
8. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
[TBL] [Abstract][Full Text] [Related]
9. Chemoproteomic Method for Profiling Inhibitor-Bound Kinase Complexes.
Fang L; Chakraborty S; Dieter EM; Potter ZE; Lombard CK; Maly DJ
J Am Chem Soc; 2019 Jul; 141(30):11912-11922. PubMed ID: 31274292
[TBL] [Abstract][Full Text] [Related]
10. Active site profiling reveals coupling between domains in SRC-family kinases.
Krishnamurty R; Brigham JL; Leonard SE; Ranjitkar P; Larson ET; Dale EJ; Merritt EA; Maly DJ
Nat Chem Biol; 2013 Jan; 9(1):43-50. PubMed ID: 23143416
[TBL] [Abstract][Full Text] [Related]
11. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics Simulations and Structural Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing Allosteric Mechanisms and Communication Pathways from Residue Centrality.
Tse A; Verkhivker GM
J Chem Inf Model; 2015 Aug; 55(8):1645-62. PubMed ID: 26236953
[TBL] [Abstract][Full Text] [Related]
13. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
[TBL] [Abstract][Full Text] [Related]
14. Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites.
Tong M; Pelton JG; Gill ML; Zhang W; Picart F; Seeliger MA
Nat Commun; 2017 Dec; 8(1):2160. PubMed ID: 29255153
[TBL] [Abstract][Full Text] [Related]
15. Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.
Hill ZB; Perera BG; Maly DJ
Mol Biosyst; 2011 Feb; 7(2):447-56. PubMed ID: 21060940
[TBL] [Abstract][Full Text] [Related]
16. The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases.
Shah NH; Amacher JF; Nocka LM; Kuriyan J
Crit Rev Biochem Mol Biol; 2018 Oct; 53(5):535-563. PubMed ID: 30183386
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for selective inhibition of Src family kinases by PP1.
Liu Y; Bishop A; Witucki L; Kraybill B; Shimizu E; Tsien J; Ubersax J; Blethrow J; Morgan DO; Shokat KM
Chem Biol; 1999 Sep; 6(9):671-8. PubMed ID: 10467133
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases.
Meng Y; Pond MP; Roux B
Acc Chem Res; 2017 May; 50(5):1193-1201. PubMed ID: 28426203
[TBL] [Abstract][Full Text] [Related]
19. Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.
Johnson TK; Soellner MB
Bioconjug Chem; 2016 Jul; 27(7):1745-9. PubMed ID: 27266260
[TBL] [Abstract][Full Text] [Related]
20. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases.
Nam NH; Lee S; Ye G; Sun G; Parang K
Bioorg Med Chem; 2004 Nov; 12(22):5753-66. PubMed ID: 15498652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
